Related Experiment Video
Updated: May 3, 2026
05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.9K
Lessons learned from developing a drug evidence base to support pharmacovigilance.
1Department of Biomedical Informatics, Vanderbilt University School of Medicine , Nashville, Tennessee, USA.
Applied Clinical Informatics
|January 24, 2014
Summary
Extracting medication information from public sources presents challenges. Current systems struggle with uniform representation and complexity, leading to inaccuracies in drug indications and adverse effects (ADEs).
Area of Science:
- Pharmacovigilance and Drug Informatics
- Medical Informatics
- Computational Linguistics in Medicine
Background:
- Publicly available electronic sources are crucial for medication-related information.
- Challenges exist in extracting and representing drug indications and adverse effects (ADEs).
Purpose of the Study:
- To identify challenges in extracting and representing medication information from public electronic sources.
- To evaluate the utility of existing drug information resources.
Main Methods:
- Created and evaluated the Drug Evidence Base (DEB).
- Extracted content from National Drug File Reference Terminology, MEDLINE co-occurrence data, and DailyMed.
- Conducted statistical evaluations and human expert reviews comparing DEB with SIDER and MEDI resources.
Main Results:
- DEB, SIDER, and MEDI showed agreement but had limitations.
- Resources used disparate UMLS concepts for single indications/ADEs, causing false matches.
- Complex logical and temporal relationships of indications/ADEs are difficult to represent.
Conclusions:
- Future drug information systems need uniform and precise clinical concept representation.
- Systems must better capture the complexity of indications and ADEs for enhanced utility.
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:26Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
300
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
300